• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Effect of truncated Hepatitis B virus X protein integration on malignant potential of HCC

Research Project

Project/Area Number 16K09334
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeMulti-year Fund
Section一般
Research Field Gastroenterology
Research InstitutionHokkaido University

Principal Investigator

Goki Suda  北海道大学, 大学病院, 特任助教 (20447460)

Co-Investigator(Kenkyū-buntansha) 坂本 直哉  北海道大学, 医学研究院, 教授 (10334418)
森川 賢一  北海道大学, 医学研究院, 助教 (60384377)
Project Period (FY) 2016-04-01 – 2019-03-31
Project Status Completed (Fiscal Year 2018)
Budget Amount *help
¥4,680,000 (Direct Cost: ¥3,600,000、Indirect Cost: ¥1,080,000)
Fiscal Year 2018: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2017: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2016: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
KeywordsHBV / HCC / HBx / truncated HBx / 肝細胞癌 / HBx / インテグレーション / CSCs / 肝癌幹細胞 / 癌 / HBx
Outline of Final Research Achievements

Recently GWAS about HBV-related HCC revealed that COOH-truncated HBx was integrated in host genome at high frequency. We aimed to analyze the relationship between COOH-truncated HBx expression and CSCs which is related to malignant potential. COOH-truncated HBx(truncated HBx/HepG2) shows significantly resistant to anti-tumor agent, 5-FU. Soft gel agar colony formation assay shows that truncated-HBx/HepG2 cells make significantly more colonies than control. Flow cytometry analysis reveals that truncated HBx/HepG2 cells express high levels of CD44, one of cancer stemness maker. Subsequently we investigated what factor up-regulate CD44 in truncated HBx/HepG2 cells by Human Stem Cell PCR Array (Qiagen).This PCR-array results indicated that LTBP1 is significantly up-regulated in only Truncated-HBx/HepG2 . The expression level of CD44 were significantly down-regulated by siRNA knockdown of LTBP1. In sorted CD44high cells, LTBP1 were significantly up-regulated compared with CD44low cells.

Academic Significance and Societal Importance of the Research Achievements

HBV肝癌におけるC末端欠損HBX蛋白のインテグレーションの影響は十分には明らかなではなかった。今検討では、C末端欠損HBX蛋白のインテグレーションによりCSCsが高率に誘導される事、その機序としてLTBP-1が関与している事が明らかとなった。CSCsは抗癌剤耐性や、転移に関与する事が知られており、C末端欠損HBX蛋白のインテグレーションがみられる症例では肝癌悪性化が惹起されている事が想定され注意を要する事が初めて明らかとなった。更に、CSCsをターゲットとして治療を考えるうえでLTBP-1が新たな治療ターゲットとなりうる事を今研究で初めて明らかとなった。

Report

(4 results)
  • 2018 Annual Research Report   Final Research Report ( PDF )
  • 2017 Research-status Report
  • 2016 Research-status Report
  • Research Products

    (15 results)

All 2019 2018 2017 2016

All Journal Article (15 results) (of which Int'l Joint Research: 1 results,  Peer Reviewed: 15 results,  Open Access: 12 results,  Acknowledgement Compliant: 5 results)

  • [Journal Article] The Successful Retreatment with Glecaprevir and Pibrentasvir of Genotype 1 or 2 HCV-infected Hemodialysis Patients who Failed to Respond to NS5A and Protease Inhibitor Treatment2019

    • Author(s)
      Suda Goki、Nakai Masato、Sho Takuya、Kimura Megumi、Shimazaki Tomoe、Maehara Osamu、Shigesawa Taku、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Umemura Machiko、Kawagishi Naoki、Baba Masaru、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Sakamoto Naoya、for the NORTE Study Group
    • Journal Title

      Internal Medicine

      Volume: 58 Issue: 7 Pages: 943-947

    • DOI

      10.2169/internalmedicine.2077-18

    • NAID

      130007622183

    • ISSN
      0918-2918, 1349-7235
    • Year and Date
      2019-04-01
    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Safety and efficacy of glecaprevir and pibrentasvir in Japanese hemodialysis patients with genotype 2 hepatitis C virus infection2019

    • Author(s)
      Suda Goki
    • Journal Title

      Journal of Gastroenterology

      Volume: in press Issue: 7 Pages: 641-649

    • DOI

      10.1007/s00535-019-01556-y

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed
  • [Journal Article] Extracellular Vesicles from Amnion-Derived Mesenchymal Stem Cells Ameliorate Hepatic Inflammation and Fibrosis in Rats2018

    • Author(s)
      Ohara Masatsugu、Ohnishi Shunsuke、Hosono Hidetaka、Yamamoto Koji、Yuyama Kohei、Nakamura Hideki、Fu Qingjie、Maehara Osamu、Suda Goki、Sakamoto Naoya
    • Journal Title

      Stem Cells International

      Volume: 2018 Pages: 1-15

    • DOI

      10.1155/2018/3212643

    • NAID

      120006585982

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Liver steatosis and dyslipidemia after HCV eradication by direct acting antiviral agents are synergistic risks of atherosclerosis2018

    • Author(s)
      Kawagishi Naoki、Suda Goki、Nakamura Akinobu、Kimura Megumi、Maehara Osamu、Suzuki Kazuharu、Nakamura Akihisa、Ohara Masatsugu、Izumi Takaaki、Umemura Machiko、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ogawa Koji、Kudo Yusuke、Nishida Mutsumi、Miyoshi Hideaki、Sakamoto Naoya
    • Journal Title

      PLOS ONE

      Volume: 13 Issue: 12 Pages: 615-620

    • DOI

      10.1371/journal.pone.0209615

    • NAID

      120006866533

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] L-Carnitine Suppresses Loss of Skeletal Muscle Mass in Patients With Liver Cirrhosis2018

    • Author(s)
      Ohara Masatsugu、Ogawa Koji、Suda Goki、Kimura Megumi、Maehara Osamu、Shimazaki Tomoe、Suzuki Kazuharu、Nakamura Akihisa、Umemura Machiko、Izumi Takaaki、Kawagishi Naoki、Nakai Masato、Sho Takuya、Natsuizaka Mitsuteru、Morikawa Kenichi、Ohnishi Shunsuke、Sakamoto Naoya
    • Journal Title

      Hepatology Communications

      Volume: 2 Issue: 8 Pages: 906-918

    • DOI

      10.1002/hep4.1207

    • NAID

      120006585791

    • Related Report
      2018 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Safety and efficacy of sofosbuvir and ribavirin for genotype 2 hepatitis C Japanese patients with renal dysfunction2018

    • Author(s)
      Sho T, Suda G,, Nagasaka A, Yamamoto Y, Furuya K, Kumagai K, Uebayashi M, Terashita K, Kobayashi T, Tsunematsu I, Onodera M, Meguro T, Kimura M, Ito J, Umemura M, Izumi T, Kawagishi N, Ohara M, Ono Y, Nakai M, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
    • Journal Title

      Heptology Research

      Volume: in press Issue: 7 Pages: 529-538

    • DOI

      10.1111/hepr.13056

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] Treatment of hepatitis C in special populations.2018

    • Author(s)
      Suda G, Ogawa K, Morikawa K, Sakamoto N
    • Journal Title

      Journal of Gastroenterology

      Volume: in press Issue: 5 Pages: 591-605

    • DOI

      10.1007/s00535-017-1427-x

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Increased serum C-reactive protein and decreased urinary aquaporin 2 levels are predictive of the efficacy of tolvaptan in patients with liver cirrhosis2018

    • Author(s)
      3.Nakai M, Ogawa K, Takeda R, Ohara M, Kawagishi N, Izumi T, Umemura M, Ito J, Sho T, Suda G, Morikawa K, Sakamoto N
    • Journal Title

      Hepatolgy Research

      Volume: in press Issue: 3

    • DOI

      10.1111/hepr.12988

    • NAID

      120006551584

    • Related Report
      2017 Research-status Report
    • Peer Reviewed
  • [Journal Article] Fibroblast growth factor-2-mediated FGFR/Erk signaling supports maintenance of cancer stem-like cells in esophageal squamous cell carcinoma2017

    • Author(s)
      Osamu Maehara, Goki Suda et al.
    • Journal Title

      Carcinogenesis

      Volume: 38 Issue: 11 Pages: 1073-1083

    • DOI

      10.1093/carcin/bgx095

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection2017

    • Author(s)
      Kawagishi N, Suda G, Onozawa M, Kimura M, Maehara O, Ito J, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N
    • Journal Title

      Journal of Hepatology

      Volume: 67 Issue: 5 Pages: 1098-1106

    • DOI

      10.1016/j.jhep.2017.04.008

    • Related Report
      2017 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Retreatment with sofosbuvir, ledipasvir, and add-on ribavirin for patients who failed daclatasvir and asunaprevir combination therapy2017

    • Author(s)
      Suda G, Ogawa K, Yamamoto Y, Katagiri M, Furuya K, Kumagai K, Konno J, Kimura M, Kawagishi N, Ohara M, Umemura M, Ito J, Izumi T, Nakai M, Sho T, Natsuizaka M, Morikawa K, Tsubota A, Shimada N, Iio E, Tanaka Y, Sakamoto N; NORTE Study Group.
    • Journal Title

      J Gastroenterol

      Volume: 印刷中 Issue: 10 Pages: 1122-1129

    • DOI

      10.1007/s00535-017-1328-z

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Safety and efficacy of daclatasvir and asunaprevir in hepatitis C virus infected patients with renal impairment2017

    • Author(s)
      Suda G, Nagasaka A, Yamamoto Y, Furuya K, Kumagai K, Kudo M, Terashita K, Kobayashi T, Tsunematsu I, Yoshida J, Meguro T, Kimura M, Ito J, Umemura M, Izumi T, Tsunematsu S, Sato F, Tsukuda Y, Nakai M, Sho T, Natsuizaka M, Morikawa K, Ogawa K, Sakamoto N; NORTE Study Group.
    • Journal Title

      Hepatol Res

      Volume: 印刷中 Issue: 11 Pages: 1127-1136

    • DOI

      10.1111/hepr.12851

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Hepatitis B virus X protein impairs α-interferon signaling via up-regulation of suppressor of cytokine signaling 3 and protein phosphatase 2A.2017

    • Author(s)
      Tsunematsu S, Suda G, Yamasaki K, Kimura M, Izumi T, Umemura M, Ito J, Sato F, Nakai M, Sho T, Morikawa K, Ogawa K, Tanaka Y, Watashi K, Wakita T, Sakamoto N
    • Journal Title

      J Med Virol

      Volume: 89 Issue: 2 Pages: 267-275

    • DOI

      10.1002/jmv.24643

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Novel Treatment of Hepatitis C Virus Infection for Patients with Renal Impairment2016

    • Author(s)
      Suda G, Ogawa K, Kimura M, Nakai M, Sho T, Morikawa K, Sakamoto N.
    • Journal Title

      J Clin Transl Hepatol

      Volume: 4(4) Pages: 320-327

    • DOI

      10.14218/jcth.2016.00032

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant
  • [Journal Article] Anti-adipogenic and antiviral effects of l-carnitine on hepatitis C virus infection.2016

    • Author(s)
      Tsukuda Y, Suda G, Tsunematsu S, Ito J, Sato F, Terashita K, Nakai M, Sho T, Maehara O, Shimazaki T, Kimura M, Morikawa K, Natsuizaka M, Ogawa K, Ohnishi S, Chuma M, Sakamoto N
    • Journal Title

      J Med Virol

      Volume: 89 Issue: 5 Pages: 857-866

    • DOI

      10.1002/jmv.24692

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access / Acknowledgement Compliant

URL: 

Published: 2016-04-21   Modified: 2020-03-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi